Visualization of fibroblast activation using

Atrial fibrillation FAPI fibroblast activation positron emission tomography (PET) pulmonary vein isolation (PVI) pulse field ablation (PFA)

Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534

Informations de publication

Date de publication:
10 2023
Historique:
received: 13 11 2022
accepted: 11 01 2023
medline: 23 10 2023
pubmed: 23 3 2023
entrez: 22 3 2023
Statut: ppublish

Résumé

Pulsed-field ablation (PFA) is a novel ablation modality for atrial fibrillation (AF) ablating myocardium by electroporation without tissue-heating. With its different mechanism of tissue ablation, it is assumed that lesion creation is divergent to thermal energy sources. 26 patients (15 PFA, 11 CBA) underwent Patient characteristics were comparable between groups. In PFA, focal FAPI uptake was only observed in 3/15 (20%) patients, whereas in the CBA cohort, 10/11 (90.9%) patients showed atrial visual uptake. We observed lower values of SUV Tissue response with respect to fibroblast activation seems to be less pronounced in PFA compared to established thermal ablation systems. This functional assessment might contribute to a better understanding of lesion formation in thermal and PFA ablation potentially contributing to better safety outcomes.

Sections du résumé

BACKGROUND
Pulsed-field ablation (PFA) is a novel ablation modality for atrial fibrillation (AF) ablating myocardium by electroporation without tissue-heating. With its different mechanism of tissue ablation, it is assumed that lesion creation is divergent to thermal energy sources.
METHODS
26 patients (15 PFA, 11 CBA) underwent
RESULTS
Patient characteristics were comparable between groups. In PFA, focal FAPI uptake was only observed in 3/15 (20%) patients, whereas in the CBA cohort, 10/11 (90.9%) patients showed atrial visual uptake. We observed lower values of SUV
CONCLUSION
Tissue response with respect to fibroblast activation seems to be less pronounced in PFA compared to established thermal ablation systems. This functional assessment might contribute to a better understanding of lesion formation in thermal and PFA ablation potentially contributing to better safety outcomes.

Identifiants

pubmed: 36944827
doi: 10.1007/s12350-023-03220-8
pii: 10.1007/s12350-023-03220-8
pmc: PMC10558367
doi:

Substances chimiques

Gallium Radioisotopes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2018-2028

Informations de copyright

© 2023. The Author(s).

Références

Clin Nucl Med. 2021 Oct 1;46(10):807-813
pubmed: 34477601
PLoS One. 2009;4(3):e4757
pubmed: 19270746
Europace. 2015 Apr;17(4):566-73
pubmed: 25614338
Int J Cardiol. 2019 Jul 15;287:195-200
pubmed: 30316645
Circ Res. 2017 Apr 28;120(9):1501-1517
pubmed: 28450367
J Am Coll Cardiol. 2020 Sep 1;76(9):1068-1080
pubmed: 32854842
Europace. 2016 Aug;18(8):1170-8
pubmed: 26759125
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
J Am Coll Cardiol. 2019 Jul 23;74(3):315-326
pubmed: 31085321
J Cardiovasc Electrophysiol. 2020 Aug;31(8):2128-2135
pubmed: 32239557
Europace. 2021 Nov 8;23(11):1767-1776
pubmed: 34240134
Europace. 2021 Sep 8;23(9):1391-1399
pubmed: 33961027
Heart Rhythm. 2018 Sep;15(9):1348-1355
pubmed: 29684571
Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007781
pubmed: 31826647
J Cardiovasc Electrophysiol. 2020 Oct;31(10):2572-2581
pubmed: 32648326
J Am Coll Cardiol. 2019 Sep 10;74(10):1348-1351
pubmed: 31488272
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):475-485
pubmed: 36269382
Front Physiol. 2020 Apr 08;11:301
pubmed: 32322219
J Nucl Cardiol. 2021 Jun;28(3):812-821
pubmed: 32975729
JACC Cardiovasc Imaging. 2021 Jul;14(7):1351-1353
pubmed: 34023259
Trends Pharmacol Sci. 2017 May;38(5):448-458
pubmed: 28365093
J Nucl Med. 2019 Dec;60(12):1743-1749
pubmed: 31405922
J Cardiovasc Electrophysiol. 2020 Aug;31(8):2136-2147
pubmed: 32107812
J Cardiovasc Electrophysiol. 2022 Mar;33(3):368-370
pubmed: 35005815
Cardiovasc Res. 2014 May 1;102(2):258-69
pubmed: 24728497
Circulation. 2019 Nov 26;140(22):1779-1788
pubmed: 31630538
JACC Clin Electrophysiol. 2021 May;7(5):614-627
pubmed: 33933412
Heart Rhythm. 2019 May;16(5):754-764
pubmed: 30385383
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1553-1559
pubmed: 34778928
Clin Res Cardiol. 2020 Oct;109(10):1271-1281
pubmed: 32072262
J Cardiovasc Electrophysiol. 2012 Jul;23(7):797-9
pubmed: 22554187
Circ Arrhythm Electrophysiol. 2013 Feb;6(1):218-27
pubmed: 23424224

Auteurs

Jana Kupusovic (J)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Department of Cardiology and Vascular Medicine, University Hospital Frankfurt, Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Lukas Kessler (L)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Florian Bruns (F)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.

Jan-Eric Bohnen (JE)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Stephan G Nekolla (SG)

Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.

Manuel M Weber (MM)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Anna Lauenroth (A)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Manuel Rattka (M)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Ken Hermann (K)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Dobromir Dobrev (D)

Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX, USA.
Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montréal, QC, Canada.

Tienush Rassaf (T)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Reza Wakili (R)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Department of Cardiology and Vascular Medicine, University Hospital Frankfurt, Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Christoph Rischpler (C)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany. c.rischpler@klinikum-stuttgart.de.
Department of Nuclear Medicine, Klinikum Stuttgart, Kriegsbergstr. 60, 70174, Stuttgart, Germany. c.rischpler@klinikum-stuttgart.de.

Johannes Siebermair (J)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Krankenhaus Goettlicher Heiland, Dornbacher Strasse. 20-30, 1170, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH